Thomas Machnig

Medicine · Health Sciences

10h-index10.0kcitations27works0.02yr avg
OpenAlex↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cardiac Imaging and Diagnostics(9), Acute Ischemic Stroke Management(7), Cardiovascular Function and Risk Factors(6), Antiplatelet Therapy and Cardiovascular Diseases(5), Blood Pressure and Hypertension Studies(4)

Publications27 total

Fluid resuscitation in the ICU/sepsis – the use of albumin
2014
Albumin in hepatology
2013
Early treatment with aspirin plus extended-release dipyridamole for transient ischaemic attack or ischaemic stroke within 24 h of symptom onset (EARLY trial): a randomised, open-label, blinded-endpoint trial
The Lancet Neurology·2010· 121 cited
Stroke treatment with alteplase given 3·0–4·5 h after onset of acute ischaemic stroke (ECASS III): additional outcomes and subgroup analysis of a randomised controlled trial
The Lancet Neurology·2009· 344 cited
Multivariable Analysis of Outcome Predictors and Adjustment of Main Outcome Results to Baseline Data Profile in Randomized Controlled Trials
Stroke·2008· 437 cited
Thrombolysis with Alteplase 3 to 4.5 Hours after Acute Ischemic Stroke
New England Journal of Medicine·2008· 6.5k citedOpen Access
Effects of aspirin plus extended-release dipyridamole versus clopidogrel and telmisartan on disability and cognitive function after recurrent stroke in patients with ischaemic stroke in the Prevention Regimen for Effectively Avoiding Second Strokes (PRoFESS) trial: a double-blind, active and placebo-controlled study
The Lancet Neurology·2008· 354 citedOpen Access
Telmisartan to Prevent Recurrent Stroke and Cardiovascular Events
New England Journal of Medicine·2008· 773 citedOpen Access
Aspirin and Extended-Release Dipyridamole versus Clopidogrel for Recurrent Stroke
New England Journal of Medicine·2008· 964 citedOpen Access
Effects of aspirin plus extended-release dipyridamole versus clopidogrel and telmisartan on disability and cognitive function after recurrent stroke in patients with ischaemic stroke in the Prevention Regimen for Effectively Avoiding Second Strokes (PRoFE
2008· 8 cited
Influence of renal dysfunction on the pharmacokinetics of the selective Na+/H+ exchange inhibitor EMD 87 580 in patients with chronic heart failure
International Journal of Clinical Pharmacology and Therapeutics·2005· 3 cited
Population Pharmacokinetics of Eniporide and Its Metabolite in Healthy Subjects and Patients With Acute Myocardial Infarction
The Journal of Clinical Pharmacology·2005· 2 cited
Primary percutaneous transluminal coronary angioplasty accelerates early myocardial reperfusion compared to thrombolytic therapy in patients with acute myocardial infarction
American Heart Journal·2003· 48 cited
Digital subtraction angiography: feasibility of densitometric evaluation of left ventricular volumes and comparison to measurements obtained by the monoplane area-length-method
2002· 8 cited
MR measurements of Gd-DTPA kinetics for estimation of myocardial perfusion
2002
Measurement of left ventricular ejection fraction (EF) by densitometry from digital subtraction angiography
2002· 2 cited
The Na+/H+exchange inhibitor eniporide as an adjunct to early reperfusion therapy for acute myocardial infarction11This manuscript is dedicated to the memory of Karl-Ludwig Neuhaus (1944–2000).
Journal of the American College of Cardiology·2001· 331 cited
Evaluation of the safety and cardioprotective effects of eniporide, a specific sodium/hydrogen exchange inhibitor, given as adjunctive therapy to reperfusion in patients with acute myocardial infarction: Rationale, design and protocol of the ESCAMI study
2001· 1 cited
Evaluation of the Safety and Cardioprotective Effects of Eniporide, a Specific Sodium/Hydrogen Exchange Inhibitor, Given as Adjunctive Therapy to Reperfusion in Patients with Acute Myocardial Infarction
Heart Drug·2001· 17 cited
Klinische Sicherheit der Anwendung des Thrombozytenaggregationshemmers c7E3 in der Interventionellen Kardiologie bei 520 Patienten (Clinical safety of platelet aggregation inhibitor c7E3 in 520 patients undergoing coronary interventions)
Zeitschrift für Kardiologie·1997· 1 cited
page 1 of 2Next →

Frequent Co-authors

K. Bachmann(7), Markku Kaste(6), Danilo Toni(6), Ralph L. Sacco(4), Salim Yusuf(4), Otto W. Witte(4), Stephanie Ôunpuu(4), William A Lawton(4), Renée H. Martin(4), Gregory W. Albers(4), Philip M. Bath(4), Natan M. Bornstein(4), Christopher Chen(4), Luı́s Cunha(4), Jacques De Keyser(4), Geoffrey A. Donnan(4), Conrado J. Estol(4), Philip B. Gorelick(4), Vivian Gu(4), Karin Hermansson(4)